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Regular Article
HEMATOPOIESIS AND STEM CELLS
Aged murine hematopoietic stem cells drive
aging-associated immune remodeling
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KEY PO INT S
l Phenotypic and
functional changes in
T and B cells of old
mice are primarily
driven by aging of
HSCs.
l CASIN-treated aged
HSCs reconstitute an
immune system with a
function similar to that
in young animals.
Aging-associated remodeling of the immune system impairs its functional integrity and
contributes to increased morbidity and mortality in the elderly. Aging of hematopoietic
stem cells (HSCs), from which all cells of the adaptive immune system ultimately originate,
might play a crucial role in the remodeling of the aged immune system. We recently re-
ported that aging of HSCs is, in part, driven by elevated activity of the small RhoGTPase
Cdc42 and that aged HSCs can be rejuvenated in vitro by inhibition of the elevated Cdc42
activity in aged HSCs with the pharmacological compound CASIN. To study the quality of
immune systems stemming selectively from young or aged HSCs, we established a HSC
transplantation model in T- and B-cell-deficient young RAG12/2 hosts. We report that both
phenotypic and functional changes in the immune system on aging are primarily a con-
sequence of changes in the function of HSCs on aging and, to a large extent, independent
of the thymus, as young and aged HSCs reconstituted distinct T- and B-cell subsets in
RAG12/2 hosts that mirrored young and aged immune systems. Importantly, aged HSCs treated with CASIN rees-
tablished an immune system similar to that of young animals, and thus capable of mounting a strong immune response
to vaccination. Our studies further imply that epigenetic signatures already imprinted in aged HSCs determine the
transcriptional profile and function of HSC-derived T and B cells. (Blood. 2018;132(6):565-576)
Introduction
Aging is associated with a variety of changes in the immune
system, summarized as aging-associated immune remodeling
and dysfunction (AAIR). Although the immune system in the
elderly seems to be at least partially competent to respond to
newly encountered antigens, age-related alterations impair its
functional integrity, resulting in an increased susceptibility to
infections and decreased responsiveness to vaccines.1,2 AAIR is
thus thought to be a major cause of the increased morbidity and
mortality in the elderly.3
Almost all constituents of the human andmurine immune system
are affected in the elderly. T cells present with prominent
changes, primarily including a decrease in the number of naive
T cells that are competent to respond to new antigens.4 For
T cells, the involution of the thymus has been seen as a critical
factor contributing to reduced lymphopoiesis on aging, as the
involution precedes T-cell-related immune incompetence.5
However, novel emerging data suggest that the reduced pro-
duction of lymphocytes in both aged mice and humans might
also depend on cell intrinsic changes in hematopoietic stem cells
(HSCs) from which lymphocytes are ultimately derived.6-8 Aged
HSCs show an altered differentiation capacity: they are skewed
toward the myeloid lineage, resulting in an overall reduced
production of lymphoid precursors.9 Although the role of thymic
involution for AAIR has been described in detail,5,10,11 there is
only limited information available on the extent to which aged
HSCs contribute to AAIR.
We recently demonstrated that an increase in the activity of the
small RhoGTPase cell division control protein 42 (Cdc42) in aged
HSCs is causative for their aging.12,13 Cdc42 cycles between
an inactive, GDP-bound and an active, GTP-bound form. A shift
from canonical to noncanonical Wnt signaling resulting from
elevated expression of Wnt5a in old HSCs results in elevated
Cdc42 activity in these HSCs.13 The elevated activity of Cdc42 is
causative for a loss in HSCs polarity for several proteins (eg,
tubulin and Cdc42 itself). Pharmacological inhibition of the el-
evated Cdc42 activity in aged HSCs to the level found in young
ones with the Cdc42 activity-specific inhibitor CASIN reverts
these age-associated phenotypes, and in serial transplantation
experiments, CASIN-treated aged HSCs function similar to
young HSCs.12 CASIN reduces Cdc42 activity by interfering with
the GTP loading exchange reaction in a dose-dependent and
reversible manner.14 We thus hypothesized that CASIN-treated
© 2018 by The American Society of Hematology blood® 9 AUGUST 2018 | VOLUME 132, NUMBER 6 565
For personal use only.on April 10, 2019. by guest  www.bloodjournal.orgFrom 
95
B6.SJL
CD45.1
YOUNG (Y)
A
B
C D
600 Y
LT-HSCs
Donor
YOUNG
(DY)
50 80 100
80
60
40
20
0
100
DY
DO
80
60
40
20
0
60
40
20
3.0×107 1.5×107
1.0×107
5.0×106
1.5×107
1.0×107
5.0×106
0 0
2.0×107
1.0×107
0
0
40
30
*
****
****
****
*
****
***
***20
10
100
80
60
40
20
DY DO D
Y
DOO
Y DY DOO
Y
DY DOO
Y
0
0
0 
we
ek
s
4 
we
ek
s
8 
we
ek
s
12
 w
ee
ks
B cells
(CD19+)
T cells
(CD3+)
myeloid cells
(Gr-1+Mac-1+, Gr-1+, Mac-1+)
Donor Contribution
(CD45.1+)
0 
we
ek
s
4 
we
ek
s
8 
we
ek
s
12
 w
ee
ks
0 
we
ek
s
4 
we
ek
s
8 
we
ek
s
12
 w
ee
ks
0 
we
ek
s
4 
we
ek
s
8 
we
ek
s
12
 w
ee
ks%
 o
f d
on
or
-d
er
ive
d 
W
BC
%
 d
on
or
-d
er
ive
d 
W
BC
Ab
so
lu
te
 n
um
be
r o
f
CD
19
+
 B
 ce
lls
 / 
sp
le
en
Ab
so
lu
te
 n
um
be
r o
f
CD
3+
CD
4+
 T 
ce
lls
 / 
sp
le
en
Ab
so
lu
te
 n
um
be
r o
f
CD
3+
CD
8+
 T 
ce
lls
 / 
sp
le
en
Donor
OLD
(DO)
recipients:
young RAG1-/-
CD45.2
6,5 Gy
600 O
LT-HSCs
B6.SJL
CD45.1
OLD (O)
F
*** *** **
80
50
40
30
20
10
0
60
40
20
Th
ym
us
 w
ei
gh
t (
m
g)
Y O
RA
G
1
-/
-
D
Y
D
O
0
G gate: Iymphocytes
Thymus RAG1-/- DY
6
HSC
CD
8 
Pa
cifi
c B
lu
e
transfer
4
100
100
101
CD4 PerCPCy5.5
101
102
102
103
103
104
104
15 64 9
19875
DO
E
DY DO
10 mm10 mm
RAG1-/-
HSC
transfer
****
***
*
Figure 1. Transplantation of DY andDOHSCs in RAG12/2 recipients. (A) Schematic representation of the experimental setup: 600 HSCs were isolated from young (Y) and old
(O) B6.SJL (CD45.1) mice and subsequently transplanted into irradiated young RAG12/2 (CD45.2) recipients. (B) Contribution of DY and DO HSCs (CD45.1) to white blood cells
was analyzed in peripheral blood every 4 weeks up to 12 weeks (DY, DO, n5 15). (C) 12 weeks posttransplantation, recipient mice were scarified and donor contribution to total
white blood cells in spleen was analyzed (DY, n5 16; DO, n5 19). (D) Absolute number of donor-derived splenic CD191 B cells, CD31CD41 and CD31CD81 T cells in recipient
animals and nontransplanted young and aged B6.SJL mice (Y, n5 8; O, n5 7; DY, n5 16; DO, n5 19). (E) Representative gross anatomy of thymi taken from a nontransplanted
RAG12/2mouse and RAG12/2 recipients transplanted with DY or DO HSCs. (F) Weight of thymus glands isolated from nontransplanted young and aged B6.SJL mice, RAG12/2
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aged HSCs might reconstitute an immune system that is similar
to that found in young mice.
In this study, we demonstrate that HSCs from young or aged
mice regenerate distinct adaptive immune systems on trans-
plantation into RAG12/2 mice that resemble the altered T- and
B-cell systems of young and aged mice. CASIN-treated aged
HSCs reconstitute a functional immune system in RAG12/2 hosts
that was similar to the one found in recipients of young HSCs,
as indicated by reestablishing a CD81 T-cell response to DNA
vaccination, as well as gene expression profiles in HSC-derived
T and B cells.
Materials and methods
Mice
Female young (2-3months) B6.129S7-Rag1tm1Mom/J (RAG12/2), young
(2-3 months) and aged (.20 months) B6.SJL-PtprcaPepcb/BoyJ
(B6.SJL), and young (2-3 months) C57BL/6Jmice were used. Mice
were kept under standard pathogen-free conditions in the animal
facility of Ulm University.
Cell sorting
HSCs were sorted as lin2Sca-11c-kit1CD342Flk-22 cells from the
bonemarrow of young and agedmice, using a BD FACS Aria II or
a BD FACS Aria III (BD Bioscience).12
Noncompetitive HSC transplantation
Sorted HSCs were cultured for 16 hours, where indicated, with
5 mM CASIN (Xcessbio).12 Six hundred HSCs were transplanted
into sublethally (6.5 Gy) irradiated RAG12/2mice. Characterization
of the recipients’ immune system was performed 12 weeks
posttransplantation except where otherwise specified.
Flow cytometry
For characterization of the immune systems, peripheral blood
and spleen immunostaining was performed according to stan-
dard protocols, using the antibodies listed in supplemental
Table 1, available on the Blood Web site.
DNA immunization
Mice were immunized with 100 mg pCI/C vector DNA intra-
muscularly (tibialis anterior muscles).15 At 12 to 13 days
postvaccination, Kb/C93-100-specific CD81 T-cell frequencies
in spleen and liver were determined using Kb/C93-100-loaded
H2Kb dimers.15
More detailed and additional materials and methods can be
found in the supplemental Material.
The RNA Seq raw data of the study are available in the Gene
Expression Omnibus repository (accession no. GSE107007).
Results
Reconstitution of RAG12/2 mice with HSCs
recapitulates reduced lymphoid contribution of
aged HSCs
We initially set out to investigate the role of aging of HSCs
for AAIR. The outcome of standard HSC transplantation into
immune-competent recipients is difficult to interpret because of
interference of radiation-resistant cells from the recipient that
might confound results16 (supplemental Figure 1A-B). To over-
come this limitation, 600 HSCs (Lin2Sca-11c-kit1CD342Flk-2-;
supplemental Figure 1C) from the bone marrow of young and
old CD45.11 B6.SJL mice were transplanted into sublethally
irradiated T- and B-cell-deficient young CD45.21 RAG12/2
mice (Figure 1A). In this setting, young and aged donor HSCs
are exposed to a young microenvironment, and the devel-
opment of HSC-derived T cells proceeds in the presence of a
young thymus.
Twelve weeks posttransplantation, recipients of aged (DO) HSCs
showed fewer donor-derived B cells but more myeloid cells in
peripheral blood compared with recipients of young (DY) HSCs
(Figure 1B). Overall reconstitution with DO HSCs resulted in
fewer donor-derived cells in the spleen than with DY HSCs
(Figure 1C). Furthermore, absolute numbers of B, CD41, and
CD81 T cells in recipients of DO HSCs were decreased com-
pared with recipients of DY HSCs (Figure 1D).
Transplantation of aged HSCs resulted in fewer
naive T cells
The development of mature single positive naive T cells de-
pends on a functional thymus.5,10,11 In recipients of DY HSCs,
thymus weight was significantly increased compared with in
nontransplanted RAG12/2 mice, and these thymi contained
high numbers of distinct T-cell progenitors including double-
negative, double-positive, and single-positive CD41 and CD81
T cells (Figure 1E-G). In contrast, in recipients of DO HSCs,
there was only a slight increase in thymus weight, and the
numbers of double-positive T-cell progenitors were reduced
(Figure 1E-G). These findings demonstrated that the “dor-
mant” thymus in RAG12/2 mice at least partially resumed its
appropriate function after adoptive transfer of DY and DO
HSCs.
One hallmark of AAIR in mice (and man) is a reduced frequency
of naive (CD442CD62L1) T cells.17 The CD81 T-cell pool in the
spleen of young B6.SJL mice contained 50% to 70% naive CD81
T cells while their frequency decreased to 3% to 10% in old mice
(Figure 2A-C). Concurrently, the frequency of CD441 memory
CD81 T cells increased on aging, filling about 90% of the CD81
T-cell pool in aged mice but only 30% to 50% in young mice
(Figure 2A-B). The frequencies of naive andmemory CD81 T-cell
subsets in recipients of DY or DO HSCs resembled the CD81
T-cell pools of young and old mice, respectively (Figure 2A-C).
A similar distribution of CD81 T-cell subsets evolved in RAG12/2
Figure 1 (continued)mice, and RAG12/2 recipients transplanted with DY and DO HSCs (Y, n5 4; O, RAG12/2, n5 3; DY, n5 5; DO, n5 8). (G) Representative thymic profile of
nontransplanted RAG12/2 mice and RAG12/2 hosts of DY and DO HSCs. Total thymic cells from transplanted and nontransplanted animals were analyzed for CD4 and CD8
expression, using flow cytometry. CD41, CD81, and CD41CD81 T cells were gated as mononucleated cells within the lymphocyte population. *P , .05; **P , .01; ***P , .001;
and ****P, .0001. (B) Two-tailed unpaired Student’s t-test, mean6 SEM. (C-D) Two-tailed unpaired Student’s t-test, mean1 SEM. (D) Only means of nontransplanted
young vs aged mice and recipients of DY vs DO HSCs were compared statistically. (F) Two-tailed unpaired Students’s t-test, one-way ANOVA, mean 1 SEM.
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Figure 2. Phenotypic characterization of splenic CD81andCD41T cells in RAG12/2 recipients. (A-B) To identify naive andmemory CD81 T cells, splenocytes were stained for
CD3, CD8, CD62L, and CD44 expression. Shown are representative flow cytometry profiles of naive (CD442CD62L1), central memory (CM; CD441CD62L1), and effector memory
(EM; CD441CD62L2) T cells within the CD31CD81 T cells from young and aged nontransplanted mice and RAG12/2 recipients of DY and DO HSCs. (C) Quantification of naive
CD31CD81 T cells within the total CD31CD81 population (Y, n5 8; O, n5 7; DY, n5 16; DO, n5 19). (D) Proliferation of CD31CD81 T cells isolated from young and old animals
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mice transplanted with C57BL/6-derived (CD45.21) DY HSCs
(supplemental Figure 2), validating that this phenotype is in-
dependent of the congenic CD45.1 interval in B6.SJL ani-
mals.18 Aged B6.SJL mice and recipients of DO HSCs showed
a higher frequency of CD441CD62L2 effector memory CD81
T cells compared with young mice and recipients of DY HSCs
(Figure 2A-B). The higher frequencies of memory T cells in aged
mice and DO HSC recipients might imply a higher proliferative
activity of these T cells.19 However, in comparison with naive
CD81 T cells, the CD441memory CD81 T-cell pool in young and
old mice and in recipients of DY and DO HSCs showed elevated
frequencies of cells that express the proliferation marker Ki-67
(Figure 2D). The higher number of memory CD81 T cells in aged
mice might thus not be a direct consequence of a different cell
cycle activity on aging. Finally, the frequency of CD81 T cells that
express inhibitory receptors usually associated with exhaustion,
such as PD-1, CD244.2, LAG-3, or TIM-3,20,21 was higher in old
mice and in recipients of DO HSCs when compared with young
mice and recipients of DY HSCs (Figure 2E-F).
The CD41 T-cell pool in young mice contained about 70%
naive CD442CD41 T cells, which declined to less than 10% in
aged mice, whereas the frequency of memory CD441CD41
T cells was elevated in aged animals (Figure 2G-I). Similar to
the reconstitution of CD81 T cells by HSCs, the frequencies of
naive and memory CD41 T-cell subsets in recipients of DY and
DO HSCs resembled the CD41 T-cell pools of young and
aged mice, respectively (Figure 2A-B,G-H). The frequencies
of naive CD41 T cells were significantly higher in recipients of
DY HSCs compared with recipients of DO HSCs (Figure 2G-I).
Young and aged HSCs thus directly contribute to the gen-
eration of distinct naive and memory CD81 and CD41 T-cell
subsets in transplanted hosts that are also found in young and
old mice.
Aged HSCs confer an increase in the frequency of
regulatory T cells
Regulatory Foxp31CD41 T cells (Tregs) are critical for the reg-
ulation of adaptive immune responses.22 In line with previous
reports,23 aged mice showed a higher frequency of Tregs. The
CD41 T-cell pool in the spleen of young mice contained about
10% to 15% Tregs, whereas their frequency increased up to 35%
in old mice (Figure 3A-B). Higher frequencies of Tregs were also
found in recipients of DO HSCs compared with recipients of DY
HSCs, whereas the difference was less pronounced but still
significant (Figure 3A-B). Moreover, the frequency of Tregs that
coexpress the transcription factor Helios24 was higher in aged
mice and recipients of DO HSCs (Figure 3C-D). Helios expres-
sion is prominent but not exclusive in thymus-derived Tregs, and
Helios1Foxp31 Tregs are known to exhibit superior suppressive
activities compared with Helios2Foxp31 Tregs.25 Aged HSCs
also contribute to the increase in the frequency of distinct Tregs
in old animals.
Increased frequency of age-associated B cells in
recipients of DO HSCs
Age-associated B cells (ABCs)26 are characterized by a lack
of both CD21/35 and CD23 expression and represent an
exhausted B-cell subset.27 The percentage of ABCs in the CD191
B-cell pool was higher in the spleen of old compared with young
mice (Figure 3E-F).26 The frequency of CD21/351CD231 follic-
ular B cells was lower in old animals, whereas the frequency of
CD21/35hiCD232 marginal zone B cells did not differ between
young and old animals (Figure 3E-F). Similarly, compared with
DY HSC recipients, transplants of DO HSCs presented with a
higher frequency of ABCs, a lower frequency of follicular B cells,
and no difference in marginal zone B cells (Figure 3E-F). Mice
transplanted with HSCs thus showed a reconstitution of B-cell
subsets resembling those found in young and old mice
(Figure 3E-F). Therefore, aged HSCs also contribute to the age-
associated changes in CD191 B-cell subsets.
The immune systems in aged mice and
recipients of DO HSCs show a reduced DNA
vaccination response
To examine the function of the immune systems, vaccination
experiments were performed. DNA-based vaccination is an
attractive technique to elicit antigen-specific CD81 T-cell re-
sponses in mice because they allow direct antigen expression
and MHC class I-restricted epitope presentation by in vivo
transfected APCs.28-30 A hepatitis B virus Core antigen-expressing
pCI/C vector induced core-specific CD81 T cells in young and
aged mice, but the frequency of de novo primed Kb/C93-100
dimer1 CD81 T cells15 was significantly lower in aged mice
(supplemental Figure 3). Similarly, compared with recipients of
DY HSCs, a significantly lower frequency of Kb/C93-100 dimer1
CD81 T cells was found in vaccinated recipients of DO HSCs
(Figure 4A-C). These data support a novel concept in which pri-
marily the age of HSCs determines the magnitude of the CD81
T-cell response to vaccination.
CASIN-treated aged HSCs restore an efficient
CD81 T-cell response to DNA vaccination
We previously reported that the elevated activity of the small
RhoGTPase Cdc42 is causative for aging of HSCs. Ex vivo
treatment of aged HSCs with the Cdc42 inhibitor CASIN reverts
the aging-associated phenotypes of HSCs.12 CASIN is thus
thought to rejuvenate aged HSCs.12 As a consequence, we
hypothesized that the functional decline of the old immune
system in recipients of DO HSCs (Figure 4B-C) might be at-
tenuated by CASIN-treatment of aged HSCs.
We transplanted untreated aged HSCs (DO) or CASIN-treated
aged HSCs (DO1C) into RAG12/2 mice (Figure 4D), followed
by a single injection of the pCI/C vector at 12 weeks post-
transplantation. Compared with recipients of DO HSCs, the
frequencies of Kb/C93-100-specific dimer1 CD81 T cells were
Figure 2 (continued) and RAG12/2 recipients of DY and DO HSCs was analyzed by expression of the nuclear protein Ki-67. Percentage of naive (CD442) and memory (CD441)
CD31CD81 T cells, which are Ki-671, are depicted (Y, O, n5 4; DY, n5 5; DO, n5 9). (E) CD31CD81 T cells isolated from nontransplanted young and old B6.SJL mice and
RAG12/2 hosts transplanted with DY or DO HSCs were stained for the exhaustion marker PD-1, CD244.2, TIM-3, and LAG-3. Representative flow cytometric profiles of
individual stains are depicted. (F) Percentages of the different inhibitory receptors within CD31CD81 T cells are shown (Y, n5 8; O, n5 7; DY, n5 16; DO, n5 19). (G-H)
Splenic naive CD41 T cells from recipients of DY and DOHSCs and nontransplanted young and agedmice were identified as CD442CD62L1 cells within the CD31CD41
T-cell population. Representative dot plot profiles of the flow cytometric analysis are depicted. (I) Quantification of naive CD31CD41 T cells within the total CD31CD41
population (Y, n 5 8; O, n 5 7; DY, n 5 16; DO, n 5 19). *P , .05; **P , .01; ***P , .001; ****P , .0001 2-tailed unpaired Student’s t-test, mean 1 SEM.
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significantly higher in spleen and liver of recipients of DO1C
HSCs (Figure 4E-F). The frequencies of Kb/C93-100-specific CD81
T cells in vaccinated recipients of DO1C and DY HSCs were very
similar (Figure 4C,F). DO1C HSCs thus generate an immune
system capable of mounting a strong CD81 T-cell response to
DNA vaccination. Recipients of DO and DO1C HSCs showed
similar frequencies of donor-derived white blood cells in the
spleen and a slight increase in the frequencies of B cells (sup-
plemental Figure 4A-B). However, we observed a significant
increase in the frequency of naive CD81 T cells and a strong
trend toward a higher frequency of CD41 T cells in recipients
of DO1C HSCs when compared with recipients of DO HSCs
(supplemental Figure 4C-D). These elevated frequencies of
T-cell subsets in DO1C recipients might explain, at least
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Figure 3. Regulatory T- and B-cell subsets in HSC trans-
planted RAG12/2 mice. To identify regulatory T cells,
splenocytes were stained for surface expression of CD3 and
CD4 as well as intracellular FoxP3 expression. Representative
graphs of individual stains for FoxP3 as well as quantification
of FoxP31 cells within the CD31CD41 population are shown
in (A) and (B), respectively (Y, n5 8; O, n5 7; DY, n5 15; DO,
n5 17). Regulatory T cells coexpressing the Ikaros zinc finger
transcription factor Helios were identified within the FoxP31
population. (C) Representative dot plot profiles of the un-
derlying flow cytometric analysis and (D) quantification of
Helios1 regulatory T cells within the FoxP31 population
(Y, n 5 5; O, n 5 5; DY, n 5 4; DO, n 5 7). For characteriza-
tion of splenic B cells, CD191 cells from young and old non-
transplanted B6.SJL mice and RAG12/2 recipients of DY and
DO HSCs were stained for follicular B cells (FOB; CD21/351
CD231), marginal zone B cells (MZ; CD21/35highCD232), and
age-associated B cells (ABC; CD21/352CD232). Shown are
representative graphs of individual stains (E) and quantifi-
cation of these B-cell populations within the total CD191
population (Y, n 5 8; O, n 5 7; DY, n 5 13; DO, n 5 16)
(F). *P , .05; **P , .01; ***P , .001; ****P , .0001, 2-tailed
unpaired Student’s t-test, mean 1 SEM.
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partially, the ability to mount the elevated frequency of Kb/C93-
100-specific CD81 T cells in these mice.
DY and DO1C HSCs generate comparable gene
expression profiles in T and B cells
To obtain information on the extent to which CASIN treatment of
aged HSCs affects the gene expression profile of daughter B and
T cells, RNAseq analyses were performed on naive CD41 T cells
and CD191 B cells isolated from DO, DO1C, or DY HSC re-
cipients (Figure 5). In RNAseq analysis, we identified 137 sig-
nificantly differentially expressed protein-coding genes by
comparing CD41 T cells isolated from recipients of DY to DO
HSCs. Similarly, comparison of CD41 T cells isolated from re-
cipients of DO1C and DO HSCs revealed 67 significantly dif-
ferentially expressed genes. Thirty genes were in common
between the 2 analyses, where 26 genes were up- and 4 were
downregulated (Figure 5B; supplemental Table 2). Unsupervised
clustering-based heat map of these differentially expressed
genes showed that DO1C HSC recipients primarily clustered
with DY HSC recipients, with only 1 of the 3 samples falling into
the DOHSCs cluster (Figure 5B). In the analysis of CD191 B cells,
we identified 169 and 103 protein-coding genes significantly
differentially expressed by comparing cells isolated from
recipients of DY to DO HSCs and DO1C to DO HSCs
(Figure 5C). Forty-seven of these genes were in common
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Figure 4. Priming CD81 T-cell responses in HSC-transplanted
RAG12/2 hosts by DNA vaccination. (A) Schematic repre-
sentation of the experimental set-up: 12 weeks after trans-
plantation, recipient mice were immunized with pCI/C DNA
encoding the hepatitis B virus Core antigen. Thirteen days after
immunization, splenic Kb/C93-100 dimer1CD81 T-cell frequencies
were determined by flow cytometry. Representative graphs of
individual stains as well as quantification of the KbC93-100 dimer
staining are shown in (B) and (C), respectively (DY, n 5 9; DO,
n5 8). (D) Schematic representation of the experimental set-up.
HSCs were isolated from old B6.SJL mice and cultured for
16 hours 6 5 mM CASIN. Subsequently, 600 HSCs were trans-
planted in subleathally irradiated young RAG12/2 mice. Twelve
weeks after transplantation, recipient mice were immunized
with themammalian expression vector pCI/C. Thirteen days after
immunization, transplanted mice were sacrificed and the per-
centage of Kb/C93-100 dimer1 cells was determined within the
CD31CD81 population by flow cytometry. Quantification as well
as representative graphs of the Kb/C93-100 dimer staining for
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between the 2 comparisons and showed the same direction
of change in expression (33 genes upregulated, 14 genes
downregulated; Figure 5C; supplemental Table 3). Un-
supervised hierarchical clustering of these genes revealed
that B cells isolated from recipients of DY and DO1C HSCs
clustered together, whereas those from DO HSCs formed a
separate cluster (Figure 5C).
Most prominent in the upregulated gene expression profile of
naive CD41 T cells from DO HSC recipients were genes im-
plicated in Treg functions (itgae, ikzf2, folr4, lag3) and in-
flammation (penk, adam19, coro2a)31 (Figure 5B). In CD191
B cells from DO HSC recipients, we found altered expression of
genes associated with cellular senescence (abl1, irs2, rrm2,
s100a8), the cytokine/chemokine network (ccl5, scimp), cell
proliferation (mki67, racgap1, top2a), cell migration (ccr7,
cmtm6, cnr2), and B-cell receptor signaling (fosb). Furthermore,
the expression of the transcription factor t-bet, a key attribute of
ABCs,32 was upregulated in CD191 B cells from DO HSC re-
cipients (Figure 5C).
To identify pathways and biological processes altered in
recipients of DY, DO1C, and DO HSCs, we performed gene
set enrichment analysis (GSEA). Gene ontology (GO) analysis
revealed significant enrichment (false discovery rate [FDR]
q value , 0.05) of 29 and 20 gene sets in naive CD41 T cells
isolated from recipients of DY and DO1C HSCs when
compared with recipients of DO HSCs (Figure 5D). We
identified 6 overlapping gene sets downregulated in recip-
ients of DY and DO1C HSCs compared with recipients of
DO HSCs (Figure 5D). Chromatin organization (GO_DNA
Packaging Complex and GO_DNA Packaging) and mitosis
(GO_Mitotic Sister Chromatid Segregation) were among the
significantly deregulated gene sets, implying that naive
CD41 T cells isolated from recipients of DO HSCs might show
an altered chromatin or mitotic transition structure as com-
pared with T cells isolated from recipients of DY and DO1C
HSCs. Importantly, CASIN-treatment of aged HSCs (DO1C)
resulted in a gene expression profile for chromatin structure
in naive CD41 T cells similar to the profile found in CD41
T cells of DY HSC recipients.
Figure 5 (continued) DO (green circle). Normalized enrichment scores (NES) of GO categories differentially expressed in the same direction between the 2 groups are depicted.
(E-F) Venn diagrams showGSEAof significantly enrichedGOand REACTOMEgene sets, respectively, differentially expressed in CD191B cells betweenDY vsDO (orange circle) and
DO1C vs DO (violet circle). NES of GO and REACTOM categories differentially expressed in the same direction between the 2 groups are depicted. (G) GSEA enrichment plots of
correlation between gene sets previously identified byMirza et al.33 to be differentially expressed in naive CD41 T cells from nontransplanted young and agedmice and differentially
expressed genes between DY and DO HSC recipients as well as DO1C and DO recipients. DY, DO and DO1C, n 5 3. (D-F) FDR q-value , 0.05; (G) FDR q-value , 0.25.
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GSEA of CD191 B cells revealed 47 (DY vs DO HSC recipients)
and 15 (DO1C vs DO HSC recipients) significantly deregu-
lated GO gene sets (Figure 5E). In a similar analysis, 21 and
17 REACTOME gene sets were significantly enriched in DY vs
DO HSC recipients and DO1C vs DO HSC recipient com-
parisons (Figure 5F). Ten of the GO terms and 11 of the
REACTOME gene sets were enriched (FDR q value , 0.05) in
both DY vs DO HSC recipients and DO1C vs DO HSC re-
cipients comparisons (Figure 5E-F). Interestingly, all the
overlapping gene sets were upregulated in CD191 B cells
isolated from recipients of DO HSCs. Of significance, 9 of the
10 GO gene sets and all of the 11 REACTOME gene sets were
related to cell cycle, proliferation, and mitosis (Figure 5E-F),
indicating that B cells developing from DO HSCs might
contain an enhanced proliferation activity. In contrast, DO1C
HSCs generated B cells characterized by a proliferation
profile similar to that seen in B cells repopulated from DY
HSCs, indicating that CASIN-treatment of aged HSCs re-
stored a young B-cell compartment.
We also performed GSEA on genes previously identified by
Mirza et al.33 to be differentially expressed between naive CD41
T cells from young and aged mice. Our analysis showed an
enrichment of those genes to differentially expressed genes
(P value , .05 and FDR , 0.25) between DY and DO HSC re-
cipients (Figure 5G; supplemental Figure 5). This demonstrates
that naive CD41 T cells isolated from young mice and recipients
of DY HSCs are very similar. When comparing the differentially
expressed genes between young and aged naive CD41 T cells of
Mirza et al and differentially expressed genes between naive
CD41 T cells from DO1C and DO HSC recipients, we could
observe the same enrichment. This supports that the tran-
scriptional profile of naive CD41 T cells in DO1C HSC recipients
mimics that of CD41 T cells in DY HSC recipients, and even more
important, that naive CD41 T cells in DO1C HSC recipients
present with a transcription profile very similar to CD41 T cells
from young mice.
Discussion
Our data support that AAIR (both phenotypic and functional) is
driven to a large extent by aging of HSCs. As a consequence,
rejuvenated DO1C HSCs restore an immune system capable of
mounting a strong vaccination response, which is similar to that of
recipients of DY HSCs. Changes in the number of specific types
of immune cells (eg, CD81 T cells) developing in recipients of
DO1C HSCs, most likely in combination with an improved
function of these cells, might be a crucial driving force for
attenuating AAIR and mounting a strong vaccination response.
In this study, we primed CD81 T-cell responses by DNA-based
immunization. After a single injection of antigen-expressing
vector DNA, CD81 T-cell responses peaked at 11 to 13 days
postinjection.15 Thus, this vaccine allows the determination of
de novo primed CD81 T cells in nontransplanted mice and
recipients of HSCs under standardized conditions. DNA-based
vaccination is also of clinical interest and is tested in various
clinical trials.30
Using young RAG12/2 mice as hosts, we are able avoid con-
founding effects from cells that resist irradiation in trans-
plantation models that use immunocompetent recipients.16 In
RAG12/2 recipients, all distinct types of T and B cells are
offspring of transplanted donor HSCs in an environment initially
devoid of lymphoid cells. Transplantation into RAG12/2 mice
is thus an attractive tool to directly compare DY, DO, and
DO1C HSCs with respect to lymphoid contribution and function.
RAG12/2 mice reconstituted with DO or DY HSCs showed an
immunization response that was almost identical to that in young
and aged mice. However, the immune systems established from
transplanted HSCs in the complete absence of host T and B cells
might not be fully identical to immune systems established by
the normal developmental route and might limit the ultimate
extent of the generalization of our findings. Furthermore, mice
are housed under specific pathogen-free conditions, and the
murine immune system, although regarded as a valued model
also for AAIR in humans, is still distinct from the human immune
system.34 Therefore, some of our findings might be, with limi-
tations, also relevant for humans.
We report here that aged HSCs provide lower numbers of naive
T cells to the periphery. These findings show that aged HSCs
present with intrinsic defects that, at least in part, cause AAIR and
suggest either that aged HSCs are impaired in the production of
T-cell progenitors or that T-cell progenitors derived from aged
HSCs are impaired in thymus homing and/or interactions with
the thymic stroma,5,35 even in an environment conducive for
proper maturation of T cells in a young thymus. Aging-associated
changes in T-lymphopoiesis have been linked to thymic in-
volution.5 Our data demonstrate that aging of HSCs is able to
cause changes in T-lymphopoiesis, and in transplantation
experiments, aged HSCs mimic at least in part aged T-lym-
phopoiesis. In combination with published reports on the role
of the thymus for AAIR, the data therefore support a role for
both HSC intrinsic as well as extrinsic processes that contribute
to AAIR.
To the same extent as the frequency of naive T cells declines in
aged mice, memory T-cell subsets accumulate.17,36 The memory
T-cell pool in aged mice is thought to arise from naive CD81
T cells in response to self-peptide/MHC ligands and signaling
through various cytokines (eg, interleukin 7, interleukin 15).17
Memory-phenotype CD81 T cells are found before birth in
humans and in unimmunized mice housed under germ-free or
even antigen-free conditions, indicating that the bulk of memory
T cells in mice, and possibly to some extent also in humans, is
distinct from other types of antigen-specific memory T cells.17,37
We showed that unimmunized aged mice and recipients of DO
HSCs, but not young mice and recipients of DY HSCs, con-
tained a high number of effector memory CD81 T cells. The
thymus-independent generation of this T-cell subset may be
directly linked to the reduced numbers of naive T cells in re-
cipients of DO HSCs, and thus indirectly conferred by aged
HSCs.
Distinct interventional approaches similar to, in our example, the
inhibition of the elevated Cdc42 activity in old HSCs with
CASIN12 have been reported to attenuate aging of HSCs.38-40 As
DO1C HSCs restore an immune system capable of mounting a
strong vaccination response similar to that primed in recipients
of DY HSCs, our data further provide rationale for testing CASIN
in vivo in aged animals. Clinical relevance for a role of inhibition
of Cdc42 activity upon aging is implied by the fact that also in
humans Cdc42 activity in blood cells positively correlates with
aging, whereas gene expression association studies revealed
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a correlation between elevated Cdc42 expression in hemato-
poietic cells and morbidity.41,42
Most interestingly, the transcriptional profile of T and B cells
reconstituted from DY and DO HSCs mimicked that of T and
B cells in young and aged animals. The profile of T and B cells
derived from DO1C HSCs was more like the profile of young
T and B cells. The differentially expressed genes and pathways
identified in our analyses are thus likely to be causatively linked
to AAIR in T and B cells. The data also imply that expression
profiles down to terminally differentiated T and B cells are al-
ready decided in HSCs themselves and are, at least partially,
regulated by changes in the activity Cdc42. As HSCs do not
express T- and B-cell genes, the mechanisms therefore will need
to be based on yet-to-be-identified epigenetic mechanisms that
do not directly regulate transcription. Previous publications al-
ready implied a role of epigenetic dysfunction as a contributor to
HSC aging.43 We previously showed that CASIN treatment of
aged HSCs restored the apolar distribution of the epigenetic
marker histone 4 acetylated on lysine 16 (H4K16) in the nucleus
of aged HSCs back to the polar distribution found in young
HSCs, and also restored the level of H4K16 to the higher level
seen in young HSCs. Such changes of the epigenetic make-up
in HSCs might thus direct phenotypic and functional changes
in immune cells on HSC differentiation that include a multitude
of other types and levels of epigenetic mechanisms awaiting
further investigation. In conclusion, we present an attractive
strategy to attenuate or even revert AAIR by CASIN-mediated
rejuvenation of aged HSCs.
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